| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/25/2012 | EP2477641A2 Inhibition of endosomal toll-like receptor activation |
| 07/25/2012 | EP2477636A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems |
| 07/25/2012 | EP2477632A1 Pharmaceutical combination for treating tumor |
| 07/25/2012 | EP2477619A2 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 07/25/2012 | EP2477603A2 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 07/25/2012 | EP2444492A9 Chicken-derived anti-lox-1 antibody |
| 07/25/2012 | EP2280723B1 Methods for species-specific immunocontraception of animals |
| 07/25/2012 | EP2227252B1 Adjuvant comprising vaccinium macrocarpon |
| 07/25/2012 | EP1931390B1 Compositions and methods for treatment of autoimmune disease |
| 07/25/2012 | EP1858541B1 Use of bmp antagonists to regulate hepcidin-mediated iron metabolism and treat iron deficiency |
| 07/25/2012 | EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
| 07/25/2012 | EP1592457B1 Folate-vinblastine conjugate as medicament |
| 07/25/2012 | EP1558276B1 Flaviviris fusion inhibitors |
| 07/25/2012 | EP1501921B2 Improved viral purification methods |
| 07/25/2012 | EP1423701B1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
| 07/25/2012 | EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin |
| 07/25/2012 | CN1653183B Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/25/2012 | CN102612559A Modified peptide vaccine derived from influenza m2 |
| 07/25/2012 | CN102612525A Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102612523A Compositions and methods related to protein a (spa) variants |
| 07/25/2012 | CN102612374A A method of promoting dendritic spine density |
| 07/25/2012 | CN102608333A Tuberculosis diagnostic composition and application thereof |
| 07/25/2012 | CN102604993A Immunologic adjuvant-Helicobacter pylori antigen fused protein oral vaccine and preparation method thereof |
| 07/25/2012 | CN102604979A Nucleotide sequence, fusion protein coded by nucleotide sequence, Mycobacterium tuberculosis vaccine prepared based on nucleotide sequence and preparation method of Mycobacterium tuberculosis vaccine |
| 07/25/2012 | CN102604957A Stabilized immunomodulatory oligonucleotides |
| 07/25/2012 | CN102604898A VP60 protein recombinant baculovirus carrying type O foot and mouth disease virus B cell epitope |
| 07/25/2012 | CN102603898A Fowl adenovirus group I immunity related fusion protein as well as encoding gene and application thereof |
| 07/25/2012 | CN102603895A Novel antigen-binding polypeptides and their uses |
| 07/25/2012 | CN102603894A Interferon alpha receptor 1 antibodies and their uses |
| 07/25/2012 | CN102603893A Method of providing disease-specific binding molecules and targets |
| 07/25/2012 | CN102603891A Method for preparing tetanus human immune globulin by double virus inactivation |
| 07/25/2012 | CN102603879A Recombinant soybean allergen, mutant and preparation methods and application of recombinant soybean allergen and mutant |
| 07/25/2012 | CN102600481A Adenovirus (rAdV)/Japanese encephalitis virus (JEV) replicon embedding carrier hog cholera vaccine and application of rAdV/ JEV replicon embedding carrier hog cholera vaccine |
| 07/25/2012 | CN102600479A Cryptosporidium andersoni nucleic acid vaccine with cross protection and preparation method of vaccine |
| 07/25/2012 | CN102600471A Target spot for treating septicemia |
| 07/25/2012 | CN102600470A Compound adjuvant, vaccine containing the same, and its preparation method |
| 07/25/2012 | CN102600469A Classical swine fever live vaccine |
| 07/25/2012 | CN102600468A Preparation process of avian influenza virus split vaccine containing MF59 adjuvant |
| 07/25/2012 | CN102600467A Application of beta-dextran in preparation of human dendritic cell tumor vaccine |
| 07/25/2012 | CN102600466A Anti-influenza A virus and novel universal epitope vaccine and preparing method thereof |
| 07/25/2012 | CN102600465A Newcastle disease (ND) vaccine, and its production method |
| 07/25/2012 | CN102600464A Avian influenza virus inactivated vaccine and preparation method thereof |
| 07/25/2012 | CN102600463A Production method of trivalent inactivated vaccine preventing duck infectious serositis |
| 07/25/2012 | CN102600462A Human dendritic cell tumor vaccine, preparation and application thereof |
| 07/25/2012 | CN102600461A Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 07/25/2012 | CN102600086A Preparation method for freeze-dried b-type haemophilus influenza conjugate vaccines |
| 07/25/2012 | CN102127554B Japanese encephalitis particle vaccine and preparation method and application thereof |
| 07/25/2012 | CN101947325B Vibrio paraheamolyticus bivalent DNA vaccine as well as preparation method and application thereof |
| 07/25/2012 | CN101899101B Synthetic polypeptide for researching influenza virus subunit vaccine |
| 07/25/2012 | CN101897963B Vaccine for hand-foot-and-mouth disease viruses |
| 07/25/2012 | CN101891818B Single-chain antibody in anti-human prostate-specific membrane antigen extracellular region and application thereof |
| 07/25/2012 | CN101890159B Method for preparing bivalent inactivated vaccine of tilapia streptococcus |
| 07/25/2012 | CN101879312B Broad spectrum type influenza vaccine and preparation method thereof |
| 07/25/2012 | CN101818130B gG and TK gene-deleted recombinant infectious bovine rhinotracheitis virus and application |
| 07/25/2012 | CN101797384B Tri-union compound immunopotentiator and method for preparing same |
| 07/25/2012 | CN101792491B Recombinant adenovirus HIV vaccine based on multipleseries epi-position and preparation method thereof |
| 07/25/2012 | CN101781360B Recombinant rubella virus protein and application |
| 07/25/2012 | CN101703767B Preparation method of nibrio parahaemolyticus outer membrane protein VP2850and application of immunity protective function thereof |
| 07/25/2012 | CN101675994B Therapy vaccine preparation |
| 07/25/2012 | CN101622342B Cancerous disease modifying antibodies |
| 07/25/2012 | CN101537179B Long-acting animal rabies vaccine and preparing method thereof |
| 07/25/2012 | CN101506239B Antihuman alpha9 integrin antibody and use of the same |
| 07/25/2012 | CN101492715B siRNA for suppressing human CSAG1 gene expression through RNA interference and uses of siRNA |
| 07/25/2012 | CN101492710B Uses of ZCCHC13 gene |
| 07/25/2012 | CN101380472B Use of total saponin from Panax notoginseng stalks and leaves in preparing immunoadjuvants |
| 07/25/2012 | CN101346394B TGF-beta binding compositions |
| 07/25/2012 | CN101337069B Compound plague vaccine and preparation method thereof |
| 07/25/2012 | CN101312742B Stabilizers for freeze-dried vaccines |
| 07/25/2012 | CN101120018B Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 07/25/2012 | CN101095949B Shigellae oil-emulsion inactivated vaccine and the developing method thereof |
| 07/24/2012 | US8227587 Dengue chimeric viruses |
| 07/24/2012 | US8227586 Human polyomavirus, designated the wu virus, obtained from human respiratory secretions |
| 07/24/2012 | US8227584 Ostertagia vaccine |
| 07/24/2012 | US8227581 Modified α-galactosyl ceramides for staining and stimulating natural killer T cells |
| 07/24/2012 | US8227577 Bivalent, bispecific antibodies |
| 07/24/2012 | US8227576 Antibodies against amyloid-β peptide |
| 07/24/2012 | US8227575 Cytokine zalpha11 ligand antibodies |
| 07/24/2012 | US8227487 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 07/24/2012 | US8227451 Phenylacetic acid inhibitors of cyclooxygenase |
| 07/24/2012 | US8227446 Oligodeoxynucleotide and its use to induce an immune response |
| 07/24/2012 | US8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) |
| 07/24/2012 | US8227403 A-β immunogenic peptide carrier conjugates and methods of producing same |
| 07/24/2012 | US8227243 Settings for recombinant adenoviral-based vaccines |
| 07/24/2012 | US8227211 Humanized anti-CCR2 antibodies and methods of use therefor |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8227185 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/24/2012 | US8226960 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
| 07/24/2012 | US8226959 Vaccine compositions |
| 07/24/2012 | US8226958 Modified SEB and prophylactics/remedies for immunopathy containing the same |
| 07/24/2012 | US8226957 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences |
| 07/24/2012 | US8226955 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes |
| 07/24/2012 | US8226954 Polypeptide having an improved cytosine deaminase activity |
| 07/24/2012 | US8226953 Group B Streptococcus antigens |
| 07/24/2012 | US8226952 Human antibodies against rabies and uses thereof |
| 07/24/2012 | US8226951 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody |
| 07/24/2012 | US8226950 Recombinant anti-VLA4 antibody molecules |
| 07/24/2012 | US8226949 Stabilizing alkylglycoside compositions and methods thereof |
| 07/24/2012 | US8226948 Anti-human IL-21 monoclonal antibodies |